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Comparison of the Effects of Nitroprusside and Nifedipine on Diastolic
Properties in Patients With Hypertrophic Cardiomyopathy: Altered
Left Ventricular Loading or Improved Muscle Inactivation?
WALTER J, PAULUS, MD, BEVERLY H. LORELL,* MD, FACC, WILLIAM E. CRAIG, MD,
JOSHUA WYNNE, MD, FACC, JOSEPH P. MURGO, MD, FACC, WILLIAM GROSSMAN, MD, FACC
BOSTOn, Massachusetts and San Antonio, Texas
The calcium channel blocking agent, nifedipine, has been
shown to improve indexes of left ventricular relaxation,
diastolic filling and compliance in patients with hyper-
trophic cardiomyopathy. The mechanism of action of
nifedipine on diastolic properties in patients with hy-
pertrophic cardiomyopathy is unclear and could result
from an improvement in myocardial inactivation or from
systemic vasodilation and left ventricular unloading. To
distinguish between these mechanisms, the effects of ni-
fedipine and the vasodilator nitroprusside on left ven-
tricular diastolic properties were compared in 10 pa-
tients with nonobstructive hypertrophic cardiomyopathy
using simultaneous micremanometer left ventricular
pressure and echocardiographic measurements.
Left ventricular peak systolic pressure was compa-
rable during nitroprusside infusion (132 ± 38 mm Hg)
and after nifedipine (132 ± 32 mm Hg). During nitro-
prusside infusion, the decrease in left ventricular end-
Prolonged left ventricular isovolumic relaxation, impaired
left ventricular filling and diminished left ventricular com-
pliance have been described in patients with hypertrophic
cardiomyopathy (1-5 ). The diastolic abnormalities have been
shown to be favorably modified by the administration of
calcium channel blocking agent s using computer analy sis
of M-mode echocardiogram s (6-8) and gated radionuclide
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diastolic pressure (22 ± 11 to I7 ± 11 mm Hg, p <
0.05) was associated with a decrease in left ventricular
end-diastolic dimension. In contrast, the decrease in left
ventricular end-diastolic pressure after nifedipine (22 ±
11 to 18 ± 10 mm Hg, p < 0.05) was associated with
no reduction of left ventricular end-diastolic dimensions,
suggesting an increase in left ventricular distensibility.
Compared with nitroprusside, nifedipine was associated
with less prolongation of the left ventricular isovolumic
relaxation time and less depression of the peak left ven-
tricular posterior wail thinning rate and peak left ven-
tricular internal dimension filling rate.
These data suggest that the effects of the calcium
channel blocker, nifedipine, on diastolic mechanics in
hypertrophic cardiomyopathy result not only from sys-
temic vasodilation but also from improved cardiac mus-
cle inactivation.
angiograms (9). These observations provide evidence that
the symptomatic relief of patients with hypertrophic car-
diomyopathy during calcium channel blocking therapy (10-12)
may be related to an improvement in left ventricular relax-
ation and compliance. Improved left ventricular relaxation
can result from either changes in ventricular loading or
cardi ac muscle inacti vation (13 ,14). Alterations in left ven-
tricular compliance can result from alteration of pericardial
and right ventricular constraints (15- 17) or changed muscle
tone ( 18,19). The beneficial effect of calcium channel block-
ing agent s on diastolic properties in patients with hyper-
troph ic cardiomyopathy could, therefore , be related either
to an effect of the calcium channel blocking agent on myo-
cardial inacti vation and resting tone or to systemic vaso-
dilation, which alters left ventricular loading during systole
and left ventricular external constraints during diastole . To
distinguish between these mechan isms, we compared the
effects of nitroprusside and mfedipine on left ventricular
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relaxation and filling patterns and diastolic compliance in
10 patients with nonobstructive hypertrophic cardiomyopathy.
Methods
Study group. We studied 10 patients with nonobstruc-
tive hypertrophic cardiomyopathy. The diagnosis was based
on typical clinical, echocardiographic and angiographic cri-
teria (5). Four patients (Cases 2,3,4 and 6) developed an
intraventricular pressure gradient on provocation (Valsalva
or postextrasystolic potentiation) , and six patients had no
evidence of a gradient at the time of the study. Nine patients
were in sinus rhythm, and one patient (Case 3) had a paced
rhythm. All medications were withheld 48 hours before the
study. Each patient gave informed written consent in ac-
cordance with the Brigham and Women's Hospital Human
Subjects Committee, and no complications occurred as a
result of the study. Selective coronary arteriography did not
reveal significant coronary artery stenoses in any of the
patients studied.
Hemodynamic and echocardiographic studies. Car-
diac catheterization was carried out using the brachial or
femoral artery approach . Systemic arterial pressure, pul-
monary artery wedge pressure and right atrial pressure were
measured with a fluid-filled catheter system and strain gauge
transducers and referenced to atmosphere at the mid-chest
level (20). Left ventricular pressure was recorded with a
micromanometer tip catheter (Millar Instruments) calibrated
against a mercury reference and matched simultaneously
against luminal pressure. Cardiac output was measured by
the Fick method.
Echocardiograms of the mitral valve and left ventricular
cavity were recorded with an Ekoline 20 system (Smith-
Kline Instruments) or a Mark III system (Advanced Tech-
nology Laboratories) using a 2.25 MHz transducer. Echo-
cardiograms , phonocardiograms of aortic valve closure and
single lead electrocardiograms were recorded on an Irex
continutrace 101 multiple channel recorder or a Honeywell
1858 fiberoptic recorder at a paper speed of 100 mm/s . The
echocardiograms were obtained simultaneously with hemo-
dynamic measurements. The simultaneous recording of
electronic markers and the electrocardiogram on both echo-
cardiographic dimension and left ventricular pressure re-
cordings permitted the simultaneous matching of pressure
and dimension data during subsequent data digitization.
Hemodynamic and echocardiographic studies were ob-
tained during the control period, during the intravenous
administration of nitroprusside and 20 minutes after sublin-
gual administration of 10 mg nifedipine. Control values
were reestablished 15 minutes after the administration of
nitroprusside, and repeat hemodynamic measurements were
obtained. If control conditions could not be reestablished
after the administration of nitroprusside, the patient was
excluded from the study.
Data analysis and statistics. Data were analyzed for
three consecutive beats in control conditions, during the
infusion of nitroprusside and after administration of nifed-
ipine. Quiet respiration was maintained throughout all re-
cordings to minimize respiratory fluctuations.
Left ventricular micromanometer pressure was digitized
at 5 ms intervals from the peak of the R wave of the elec-
trocardiogram to the peak of the R wave of the subsequent
beat , using a hand-controlled cursor (Graph Pen, SAC,
Southport, Connecticut), and data were processed by a Tek-
tronix 4051 computer system . A sixth order polynomial
curve was fitted to the digitized left ventricular pressure
data. The analysis was started at the left ventricular pressure
at peak negative first derivative ( - dP/dt) and stopped at the
left ventricular pressure that was equal to the peak of the
V wave of a simultaneously recorded pulmonary artery wedge
pressure tracing. A polynomial (sixth order) curve fit (cor-
relation coefficient [r] > 0.99) was performed because of
poor agreement (r < 0.99) between true data points and
points calculated from an exponential fit with non-zero ref-
erence pressure (21,22) . Similar deviations of isovolumic
left ventricular relaxation pressure from a simple monoex-
ponential decay have been reported (23,24). A sixth order
polynomial curve fit was chosen as it consistently provided
a correlation coefficient higher than 0 .99 . On a represen-
tative example (Case 3, Control T2) , a linear curve fit yielded
a correlation coefficient of 0.98 and an exponential curve
fit with non-zero asymptote yielded a correlation coefficient
of 0 .96. A correlation coefficient of 0.99 was observed from
a polynomial fit of at least the third order. A sixth order
polynomial curve fit provided additional accuracy and avoided
variability in the closeness of the fit. The contribution of
higher order (> sixth) polynomials to the closeness of the
fit was negligible. A "time constant" of left ventricular
pressure decay was calculated from the sixth order poly-
nomial as the time needed for the pressure to decrease to
l ie of its value at peak negative dP/dt.
Left ventricular septal wall endocardium and posterior
wall endocardium and epicardium were digitized at 5 ms
intervals from the peak of the R wave on the electrocardio-
gram to the peak of the R wave of the subsequent beat to
provide instantaneous data on left ventricular posterior wall
thickness and internal dimension, and a polynomial (sixth
order) was fit to the calculated left ventricular internal di-
mension data and posterior wall thickness data (8) . On the
basis of goodness of fit, a sixth order polynomial fit was
preferred over a five point parabolic fit for determination of
first and second derivatives used to calculate peak left ven-
tricular internal dimension filling (dDLv/dt [rnm/sj) or thin-
ning (dPW/dt [mm/s]) rates and the extent of rapid filling
(~DLvlmm]) or thinning (~PW[mm]). Excellent agreement
was always observed between the true data points and the
points calculated from the polynomial (r > 0.99).
The percent fractional shortening of the left ventricular
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internal dimension (%FS) was calculatedfrom the following
formula: (EDD - ESD)/EDD X 100, where EDD = left
ventricular end-diastolic dimension (mm) and ESD = left
ventricular end-systolic dimension (mm). Left ventricular
isovolumic relaxation time (lVRT [ms]) was calculated as
the interval between the first high frequency component of
the aortic valve closure sound (A2) and the opening of the
mitral valve leaflets on the echocardiogram (4,6,8). In our
laboratory, control values (mean ± standard deviation) of
isovolumic relaxation time, peak left ventricular internal
dimension filling rate and peak left ventricular posterior wall
thinning rate are 60 ± 7, 118 ± 7 and 82 ± II mm/s,
respectively. Mean isovolumic left ventricular pressure de-
cay rate (6P/IVRT [mm Hg/ms]) was obtained by dividing
the isovolumic pressure drop (left ventricular pressure at
aortic valve closure minus pulmonary artery wedge pressure
at peak V wave) by the left ventricular isovolumic relaxation
time.
Left ventricular pressure-internal dimension relations
were obtained by computer matching of corresponding left
ventricular pressure and internal dimension data points. All
data are reported as the mean ± standard deviation and
statistical significance (probability [pI < 0.05) was deter-
mined using a multiple comparison analysis (Bonferroni
method) (25). The interobserver and intraobserver varia-
bility coefficients for isovolumic relaxation time, peak in-
ternal dimension filling rate and peak posterior wall thinning
rate were less than 5%.
Results
Left ventricular and systemic hemodynamics. Indi-
vidual hemodynamic data obtained during control condi-
tions, during the administration of nitroprusside and after
the administration of nifedipine are shown in Table I. Left
ventricular peak systolic pressure was comparable during
nitroprusside infusion (132 ± 38 mm Hg) and after nifed-
ipine administration (132 ± 32 mm Hg). Both nitroprusside
and nifedipine administration were associated with an in-
crease in heart rate relative to control. Both nifedipine and
nitroprusside caused a significant decrease in left ventricular
end-diastolic pressure (from 22 ± II to 17 ± II mm Hg
[nitroprusside1 and from 22 ± II to 18 ± 10 mm Hg
[nifedipine]). Mean right atrial pressure was significantly
lower only during nitroprusside infusion (7 ± 6 to 5 ± 5
mm Hg) and cardiac index was significantly higher only
after nifedipine administration (3.5 ± 1.4 to 4.2 ± 1.7
liters/min per rrr'). The time constant T of left ventricular
relaxation was significantly reduced during nitroprusside
infusion and after nifedipine administration relative to the
control period.
Diastolic left ventricular pressure wave forms. In three
patients (Cases 1,2 and 3, Table I), an abnormal early
diastolic left ventricular pressure waveform was observed
during control conditions with an absent rapid filling phase
and a continuous pressure fall into mid-diastole, suggestive
of prolonged left ventricular inactivation (Fig, I). In two
patients (Cases 5 and 9), similar waveforms were observed
in the postextrasystolic beats under control conditions. These
waveforms have been described previously, both at rest (7)
and during exercise (26). The administration of nifedipine
restored this abnormal pressure waveform to a configuration
with a rapid filling phase in early diastole and a continuous
pressure rise in mid-diastole.
Echocardiographic assessment of left ventricular
function. Echocardiographic data obtained in control con-
ditions, during the administration of nitroprusside and after
the administration of nifedipine are shown in Table 2. For
the group, the left ventricular end-diastolic internal dimen-
sion was significantly smaller during nitroprusside infusion
with respect to both control conditions and nifedipine admin-
istration. Under equal systolic loading conditions, left ven-
tricular end-systolic internal dimension was comparable dur-
ing nitroprusside infusion and after nifedipine administration,
whereas the percent fractional shortening was significantly
higher after nifedipine administration compared with that
after nitroprusside. The isovolumic left ventricular relax-
ation time was significantly shorter after nifedipine (84 ±
25 ms) than after nitroprusside (95 ± 26 ms) despite com-
parable systolic loading. The mean isovolumic left ventric-
ular pressure decay rate (6P/IVRT) remained unaltered by
either nitroprusside infusion or nifedipine administration.
Nifedipine was associated with significant improvement in
peak posterior wall thinning rate (dPW/dt), peak left ven-
tricular internal dimension filling rate (dDLy/dt), total left
ventricular internal dimension change during diastole (6DLy)
and total left ventricular posterior wall diastolic thickness
change (6PW), with respect to both control values and the
values obtained during nitroprusside infusion.
The decrease in left ventricular end-diastolic pressure
during nitroprusside infusion was accompanied by a de-
crease in left ventricular end-diastolic internal dimension
(45.5 ± 11.0 to 41.8 ± 12.0 mm, p < 0.05). After the
administration of nifedipine, this decrease in pressure was
not associated with a reduction in internal dimension (Table
2).
The mechanism of the decrease in left ventricular end-
diastolic pressure was further analyzed by examination of
plots of the left ventricular pressure-internal dimension re-
lation. Figure 2 shows complete left ventricular pressure-
internal dimension loops obtained in control conditions, dur-
ing the infusion of nitroprusside and after the administration
of nifedipine (Case 2). After mfedipme, the area enclosed
by the pressure-internal dimension loop is larger than that
during nitroprusside infusion or control conditions, sug-
gestmg an effect of nifedipine on both diastolic compliance
and systolic loading conditions.
Table 1. Left Ventricular and Systemic Hemodynamics in 10 Patients With Nonobstructive Hypertrophic Cardiomyopathy 0000
N
HR LVPSP MAP LVEDP MRAP CI SVR T dP/IVRT
Age (yr)
(beats/min) (mm Hg) (mmHg) (mm Hg) (mm Hg) (liters/min per rrr') (dynes -s-cm - 5) (ms) (mm Hg/ms)
Case &Sex C Nit Nif C Nit Nif C Nit Nif C Nit Nif C Nit Nif C Nit Nif C Nit Nif C Nit Nif C Nit Nif z"O-:>
tilc
I 17M 73 97 82 100 88 96 86 73 82 II 7 II 5 2 4 3.3 3.1 4.7 1080 997 726 61 48 47 0.43 0.50 0.58 ot'"'_c
2 64F 96 82 90 160 103 139 115 75 98 15 7 II 5 5 8 2.7 2.6 3.0 2316 1555 1714 38 27 30 1.11 0.77 1. 14 ::!l'"Zl"l1
3 82F 76 77 80 161 149 147 105 97 93 17 9 10 7 5 5 1.7 1.7 2.3 3267 2967 2200 75 59 48 0.62 0.58 0.79
l"l1-'l
:>:>
4 48F 105 115 III 184 160 166 140 128 130 37 30 32 II 7 8 4.7 5.5 5 .5 1323 1060 1069 50 48 45 1.79 1.67 2.08 Zt'"'o '
5 68F 57 58 59 219 209 176 130 115 108 37 33 30 15 10 12 1.7 1.9 2.3 3407 2625 2021 65 56 57 1.40 1.37 1.33 ::t:
6 34F 71 89 73 106 93 95 87 80 82 21 12 12 2 2 2 3.4 4.4 3.9 1193 992 1143 59 31 27 1.28 1.03 1.:20 -<"0
l"l1
7 55F 67 71 71 121 98 103 87 70 81 39 36 35 17 17 16 2.6 2.8 3.2 1142 785 861 72 65 63 - - - ::0-'l
8 32M 78 87 83 157 126 163 128 109 130 II 15 18 I I 2 5.6 3.8 6.0 1814 2273 1706 32 33 36 1.50 1.18 1.50 ::00
9 38M 81 96 89 163 146 141 139 120 120 17 10 15 3 2 3 5.5 4.9 7.5 1978 1927 1248 40 35 39 0.75 0.95 0.87 "0::t:
10 45F 114 129 126 219 144 95 175 115 76 18 10 6 2 2 3 3.3 3. 1 3.5 2506 1739 1024 50 40 35 1.78 0.95 0.66 n
Mean 82 90 86 158 132 132 119 98 100 22 17 18 7 5 6 3.5 3.4 4.2 1993 1692 1371 54 44 42 1.2 1.0 1.1 o:>
± I SD 18 20 20 42 38 32 29 22 21 II II 10 6 5 5 1.4 1.2 1.7 861 753 505 15 13 12 0.5 0.4 0.5
::0
(n= 10) I~ I I L...+-J , ~ IL...+J I l.-+-J I ~I I ~L..+-I, 'l..+i I §III III :::
-<
*p < 0.05. C = control; CI = cardiac index; F = female; d P/IVRT = mean isovolumic pressure decay rate; HR = heart rate; LVEDP = left ventricular end-diastolic pressure; 0"0
LVPSP = left ventricular peak systolic pressure; M = male; MAP = mean arterial pressure; MRAP = mean right atrial pressure; Nif = 20 minutes after nifedipine admini stratio n; Nit :>-'l
= during nitroprusside administration; SD = standard deviation ; SVR = systemic vascular resistance; T = time constant of left ventricular pressure decay . ::t:-<
Table 2. Echocardiographic Evaluation of Left Ventricular Systolic and Diastolic Function in 10 Patients With Nonobstructive Hypertrophic Cardiomyopathy
IVRT dPW/dt dPW dDLv/dt dDLV EDD ESD %FS
(ms) (mmls) (mm) (mm) (mm) (mm) (mm)
Case C Nit Nif C Nit Nif C Nit Nif C Nit Nif C Nit Nif C Nit Nif C Nit Nif C Nit Nif
I 145 112 110 46 55 65 11.0 8.3 10.3 56 81 79 20.4 14.4 19.5 46.3 34.9 47.8 25.9 20.3 28.3 44 42 41
2 III 105 87 87 32 146 8.2 6.0 11.0 49 56 81 15.7 13.7 22.7 27.1 24.1 32.6 11.3 10.3 11.0 58 57 69
3 159 118 96 33 34 44 4.8 3.6 7.0 39 35 45 9.1 7.0 11.5 46.7 36.8 38.8 37.6 39.8 27.3 20 19 30
4 57 61 50 106 163 209 10.1 12.4 13.6 159 197 210 15.1 17.7 18.0 46.8 45 .6 47.5 31.7 27.9 29.5 32 39 38
5 80 70 57 37 39 41 7.5 7.0 9.0 82 84 88 17.9 16.4 18.5 54.8 53.7 53.3 36.9 37.3 34.8 33 31 35
6 60 65 59 39 90 93 8.3 9.4 12.8 60 110 104 14.0 17.2 20.5 50.6 49.2 52.7 36.6 32.0 32.2 28 35 39
7 - - - 66 75 105 9.6 9.1 9.6 85 102 114 18.0 19.0 20.7 68 .3 66.0 70.4 50.3 47.0 49.7 26 28 29
8 84 82 80 20 41 47 5.9 4.5 5.7 43 55 71 11.4 10.6 13.8 39.3 35.9 42.0 27.9 25.1 28.3 29 30 33
9 158 130 126 61 74 99 8.8 9.1 12.7 95 111 175 19.6 20.3 26.6 37.5 37.4 44.5 17.9 17.1 17.9 52 54 66
10 92 110 9S 37 32 52 5.0 3.5 4.6 71 60 88 9.4 12.8 12.0 36.4 34.8 33. 1 27.0 22.0 21. 1 26 37 36
Mean 105 95 84 53 64 90 7.9 7.3 9.6 74 89 106 15.1 14.9 18.4 45.4 41.8 46.3 30.3 27.9 28.0 35 37 42 Z
± I SD 40 26 25 27 41 54 2.1 2.9 3. 1 35 46 50 4.1 4.1 4.8 11.0 12.0 11.1 11.0 11.3 10.4 12 12 15
0
-e ....
W' ;U ~I }--tl-JV! ~I L...+-J~ ~ I ~I " :>(n 10) I I I I ~R
*p < 0 .05 . dDLv/dt = peak posterior wall thinning rate; dDLV = left ventricular internal dimension change during diasto le; dPW and d PW/dt = left ventricular posterior wall diastolic :.<.,00
",,-
thickness change and its first derivative; EDD = left ventricular end-diastolic internal dimension; ESD = left ventricu lar end-systolic internal dimension; IVRT = isovol umic relaxation ~N"" .
time; %FS = percent fractional shortening of the left ventricuiar internal dimension; other abbreviations as in Table I . f~
ce
'" v.
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Figure 1. Case 2, A representative ex-
ample of simultaneously recorded elec-
trocardiogram (EKG), leftventncular (LV)
micromanometer diastolic pressure and
left ventricular cavity echocardiogram in
the control state, during the administra-
tion of nitroprusside and after the admin-
istration of nifedipine. EDD = end-dia-
stolic dimension; IVS = interventricular
















Effect of nitroprusside and nifedipine on left ventric-
ular diastolic properties. Calcium channel blocking agents
have been shown to favorably modify abnormal left ven-
tricular diastolic properties in patients with hypertrophic
cardiomyopathy (1-5), but it has been unclear whether the
mechanism of these effects can be entirely ascribed to di-
minished left ventricular systolic loading via systemic vaso-
dilation or is, in part, related to improved cardiac muscle
inactivation. In our study, nitroprusside and nifedipine caused
similar reductions in left ventricular loading as assessed by
peak left ventricular systolic pressure in patients with non-
obstructive hypertrophic cardiomyopathy. However, nifed-
ipine caused greater modification of abnormal left ventric-
ular relaxation and diastolic filling patterns than that induced
by the vasodilator nitroprusside. In these patients, in com-
parison with nitroprusside, nifedipine caused greater im-
provement of prolonged left ventricular relaxation as as-
sessed by shortening of the isovolumic relaxation time and
modification of abnormal left ventricular diastolic wave-
forms. Nifedipine also was associated with significant im-
provement of the depressed peak left ventricular posterior
wall thinning rate and peak left ventricular internal dimen-
sion filling rate. Incontrast to nitroprusside, after nifedipine
the decrease in left ventricular end-diastolic pressure oc-
curred with left ventricular end-diastolic dimension un-
changed, or in some cases actually increased (Fig. 2), sug-
gesting improved left ventricular distensibility.
Effects on isovolumic relaxation time. The prolonga-
tion of the left ventricular isovolumic relaxation time and
the time constant T of relaxation observed in this study and
their modification by the calcium channel blocking agents
have been previously recognized (2,6-8). Care must be
taken in the interpretation of the values of the time constants
obtained because the isovolumic pressure decay in these
patients is not adequately approximated by a mono-
exponential function (8,27). Inthis study, the time constants
obtained from a polynomial model reflect only gross ab-
normalities in the rate of isovolumic muscle relaxation, which
appears to improve during intervention with nitroprusside
and nifedipine. The presence of profound slowing of left
ventricular muscle inactivation extending beyond mitral valve
opening is supported by the observation of an abnormal left
ventricular waveform, with a continuous pressure decrease
into mid-diastole that was restored to normal by the admin-
istration of nifedipine. The decrease in time constant T
during both nitroprusside infusion and after nifedipine
administration may reflect predominant load-dependent ef-
fects on early isovolumic relaxation (24,28). A mean iso-
volumic left ventricular pressure decay rate (6P/IVRT) was
obtained by dividing the decrease in isovolumic left ven-
tricular pressure by the isovolumic left ventricular relaxation
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Figure 2. Total left ventricular (LV) pressure-internal dimension
relations obtained in control conditions, during the infusion of
nitroprusside and after the administration of nifedipine.
time. This index of relaxation was unaffected by either
nitroprusside or nifedipine, illustrating the counterbalancing
effects of lowered aortic valve closure pressure, lowered
mitral valve opening pressure and changed intrinsic iso-
volumic left ventricular pressure decay rate after nitroprus-
side and nifedipine administration.
Effects on ventricular wall thinning and internal di-
mension. After nifedipine administration, peak left ven-
tricular posterior wall thinning and internal dimension filling
rates improved with respect to both control conditions and
nitroprusside infusion. It has been previously shown that
cardiac muscle peak lengthening velocity in physiologically
loaded papillary muscles (29) is, in part, determined by the
end-diastolic muscle length and the instantaneous load dur-
ing muscle lengthening (30). When muscle inactivation is
impaired by hypoxia or caffeine administration (31), peak
muscle lengthening velocity is depressed for the same extent
of muscle shortening (14). As there were no significant
changes in end-systolic left ventricular internal dimension
after nifedipine administration, the improvement of left ven-
tricular filling after nifedipine supports the hypothesis that
muscle inactivation was improved.
During nitroprusside infusion, left ventricular diastolic
pressure decreased to the same extent as that after nifedipine.
However, left ventricular end-diastolic dimension and right
atrial pressure were significantly reduced, associated with
a slight downward shift of the diastolic pressure-internal
dimension relation after nitroprusside. These actions of ni-
troprusside suggest an effect of systemic venous vasodila-
tion and, consequently, a reduction of left and right ven-
tricular preload. These findings are consistent with prior
observations (16,32) which have shown that downward dis-
placement of the left ventricular diastolic pressure-volume
relation occurs during vasodilator therapy and may be de-
pendent on multiple variables, including reduction of right
ventricular filling pressure and reduced coronary vascular
turgor. After nifedipine, left ventricular end-diastolic pres-
sure decreased at an unchanged left ventricular end-diastolic
dimension, which is consistent with an increase in left ven-
tricular distensibility. A smaller change in right atrial pres-
sure was observed after nifedipine, in comparison with ni-
troprusside, which argues against a predominant effect of
altered external constraints such as the pericardium or the
right ventricle on left ventricular compliance during nifedi-
pine administration.
Mechanisms of nifedipine's beneficial effects. These
observations indicate that the increase in left ventricular
distensibility after nifedipine in hypertrophic cardio-
myopathy is unlikely to be solely due to either left ventric-
ular systolic or diastolic unloading. At least three mecha-
nisms could theoretically explain nifedipine's beneficial action
on abnormal left ventricular properties in hypertrophic
cardiomyopathy.
First, coronary vasodilation (especially at the level of
the coronary microvasculature) might alleviate subendocar-
dial ischemia, thereby improving ischemia-induced changes
in cardiac muscle inactivation and compliance (19,33-37).
Second, nifedipine might directly alter intracellular cal-
cium availability, thereby restoring normal muscle tone (38).
With regard to the latter possibility, increased intracellular
calcium availability has been hypothesized to occur in hy-
pertrophic cardiomyopathy in human patients (11) and in
Syrian hamsters (39). A prolonged plateau phase of the
action potential of hypertrophied myocardium (40,41) and
a consequent increase in slow channel calcium influx might
also promote such a state of intracellular calcium overload.
However, recent studies (42) on papillary muscles isolated
from hypertrophic rat hearts have shown unaltered load de-
pendency of muscle relaxation, which implies the presence
of a normal muscle inactivation rate in isolated well oxy-
genated hypertrophied myocardium. This finding argues
against a primary aberration of intracellular calcium avail-
ability in secondary myocardial hypertrophy.
Third, nifedipine administration could induce a combi-
nation of afterload reduction and diminished contractility.
These actions could explain a decrease in left ventricular
filling pressure at an unreduced end-diastolic dimension.
However, the reduction in end-systolic dimension, the in-
crease in percent fractional shortening and the increase in
cardiac index argue against depressed contractility after ni-
fedipine administration in these patients.
Conclusions. We compared the effects of nifedipine and
nitroprusside on left ventricular relaxation, diastolic filling
and distensibility in 10 patients with nonobstructive hyper-
trophic cardiomyopathy. Despite equal decreases in left ven-
tricular peak systolic pressure after both nitroprusside and
nifedipine, nifedipine administration caused significantly more
improvement of left ventricular isovolumic relaxation time,
left ventricular filling rates and left ventricular diastolic dis-





tensibility. Therefore, the improvement in diastolic function
observed after nifedipine is unlikely to be entirely due to
left ventricular systolic unloading, Both relief of subendo-
cardial ischemia related to coronary vasodilation or the cor-
rection of an intracellular calcium overload, or both, may
contribute to the beneficial effects of nifedipine on left ven-
tricular relaxation and compliance in hypertrophic cardio-
myopathy.
We greatly appreciate the technical assistance of Alexander L. Neumann
and the typing assistance of Barbara Connolly.
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